UNSPSC 51161557: Zardaverine

This classification denotes a phosphodiesterase inhibitor and bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TQ358GWH6Y. European Medicines Agency schedules Zardaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00142MIG. Zardaverine generally arises in the molecular formula C12H10F2N2O3.

UNSPSC 51161557 Zardaverine, a Commodity code, covers generic pharmaceutical products and over-the-counter medications that state and local governments procure through cooperative purchasing agreements. State and local jurisdictions buying under this code source medications through authorized pharmaceutical wholesalers for distribution across government facilities, including correctional institutions, health departments, and public health clinics. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body identified in recent activity and operates a multi-state purchasing vehicle that includes participating state and local government facilities across multiple states.

MMCAP issued an RFP on January 20, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. Vendors must supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and meet cGMP and Drug Supply Chain Security Act (DSCSA) compliance requirements. Award criteria weight price competitiveness at 75 percent, fixed pricing at 10 percent, EDI capability and administrative fee compliance at 5 percent each, and pricing format compliance at 5 percent. The contract term is two years for new responders with optional extensions at MMCAP's sole discretion, and awarded vendors must maintain commercial general liability coverage of $5,000,000 per occurrence and network security and privacy liability of $2,000,000. Products must be available in the marketplace by May 15, 2026, with resulting agreements effective July 1, 2026. No specific budget, award value, or set-aside restrictions are disclosed in the solicitation.